281 results
Responsible body
PRAC Remove PRAC filter
-
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28 September - 1 October 2020
PRAC, Last updated: 02/10/2020 -
List item
News: PRAC recommends revoking marketing authorisation of ulipristal acetate for uterine fibroids
PRAC, Last updated: 04/09/2020 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 31 August - 3 September 2020
PRAC, Last updated: 04/09/2020 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 July 2020
PRAC, Last updated: 10/07/2020 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 June 2020
PRAC, Last updated: 12/06/2020 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 11-14 May 2020
PRAC, Last updated: 15/05/2020 -
List item
Press release: Leuprorelin depot medicines: PRAC recommends new measures to avoid handling errors
PRAC, Last updated: 15/05/2020 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 14-17 April 2020
PRAC, Last updated: 17/04/2020 -
List item
Press release: EMA review of Picato concludes medicine’s risks outweigh its benefits
PRAC, Last updated: 17/04/2020 -
List item
Press release: Suspension of ulipristal acetate for uterine fibroids during ongoing EMA review of liver injury risk
PRAC, Last updated: 13/03/2020 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9-12 March 2020
PRAC, Last updated: 13/03/2020 -
List item
Press release: Restrictions in use of cyproterone due to meningioma risk
PRAC, Last updated: 14/02/2020 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10-13 February 2020
PRAC, Last updated: 14/02/2020 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 January 2020
PRAC, Last updated: 17/01/2020 -
List item
Press release: EMA suspends Picato as a precaution while review of skin cancer risk continues
PRAC, Last updated: 17/01/2020 -
List item
Press release: PRAC confirms four-week limit for use of high-strength estradiol creams
PRAC, Last updated: 17/01/2020 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 November 2019
PRAC, Last updated: 29/11/2019 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28-31 October 2019
PRAC, Last updated: 31/10/2019 -
List item
Press release: Four-week limit for use of high-strength estradiol creams
PRAC, Last updated: 04/10/2019 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 September-3 October 2019
PRAC, Last updated: 04/10/2019 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 2-5 September 2019
PRAC, Last updated: 06/09/2019 -
List item
Press release: PRAC recommends new measures to avoid dosing errors with methotrexate
PRAC, Last updated: 12/07/2019 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 July 2019
PRAC, Last updated: 11/07/2019 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 11-14 June 2019
PRAC, Last updated: 14/06/2019 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 May 2019
PRAC, Last updated: 17/05/2019